Explore
Validate
Learn
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN360955 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Low Density Lipoprotein Receptor-Related Protein 2 (LRP2) antibody
- Antibody type
- Monoclonal
- Description
- Protein G Chromatography
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- CD7D5
- Vial size
- 0.1 mg
- Storage
- Prior to reconstitution store at 2-8°C. Following reconstitution store the antibody at -20°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Identification of megalin as the sole rat kidney sialoglycoprotein containing poly alpha2,8 deaminoneuraminic acid.
Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.
Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions.
Receptor-associated protein and members of the low density lipoprotein receptor family share a common epitope. An extended model for the development of passive Heymann nephritis.
Mapping rat megalin: the second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis.
The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
Ziak M, Kerjaschki D, Farquhar MG, Roth J
Journal of the American Society of Nephrology : JASN 1999 Feb;10(2):203-9
Journal of the American Society of Nephrology : JASN 1999 Feb;10(2):203-9
Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.
Kerjaschki D, Exner M, Ullrich R, Susani M, Curtiss LK, Witztum JL, Farquhar MG, Orlando RA
The Journal of clinical investigation 1997 Nov 1;100(9):2303-9
The Journal of clinical investigation 1997 Nov 1;100(9):2303-9
Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions.
Orlando RA, Exner M, Czekay RP, Yamazaki H, Saito A, Ullrich R, Kerjaschki D, Farquhar MG
Proceedings of the National Academy of Sciences of the United States of America 1997 Mar 18;94(6):2368-73
Proceedings of the National Academy of Sciences of the United States of America 1997 Mar 18;94(6):2368-73
Receptor-associated protein and members of the low density lipoprotein receptor family share a common epitope. An extended model for the development of passive Heymann nephritis.
Hiesberger T, Hodits R, Ullrich R, Exner M, Kerjaschki D, Schneider WJ, Nimpf J
The Journal of biological chemistry 1996 Nov 15;271(46):28792-7
The Journal of biological chemistry 1996 Nov 15;271(46):28792-7
Mapping rat megalin: the second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis.
Saito A, Yamazaki H, Rader K, Nakatani A, Ullrich R, Kerjaschki D, Orlando RA, Farquhar MG
Proceedings of the National Academy of Sciences of the United States of America 1996 Aug 6;93(16):8601-5
Proceedings of the National Academy of Sciences of the United States of America 1996 Aug 6;93(16):8601-5
The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
Farquhar MG, Saito A, Kerjaschki D, Orlando RA
Journal of the American Society of Nephrology : JASN 1995 Jul;6(1):35-47
Journal of the American Society of Nephrology : JASN 1995 Jul;6(1):35-47
No comments: Submit comment
No validations: Submit validation data